Prime Capital Investment Advisors LLC Reduces Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Prime Capital Investment Advisors LLC trimmed its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 3.6% in the 3rd quarter, Holdings Channel reports. The fund owned 129,444 shares of the company’s stock after selling 4,846 shares during the quarter. Prime Capital Investment Advisors LLC’s holdings in VanEck Pharmaceutical ETF were worth $12,301,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. Private Advisory Group LLC increased its stake in shares of VanEck Pharmaceutical ETF by 0.3% in the 2nd quarter. Private Advisory Group LLC now owns 37,994 shares of the company’s stock worth $3,476,000 after acquiring an additional 128 shares in the last quarter. Optimum Investment Advisors bought a new stake in VanEck Pharmaceutical ETF during the 2nd quarter valued at about $27,000. Beck Capital Management LLC increased its stake in VanEck Pharmaceutical ETF by 1.5% during the 2nd quarter. Beck Capital Management LLC now owns 21,274 shares of the company’s stock valued at $1,946,000 after purchasing an additional 317 shares in the last quarter. Assetmark Inc. increased its stake in VanEck Pharmaceutical ETF by 5.8% during the 3rd quarter. Assetmark Inc. now owns 6,491 shares of the company’s stock valued at $617,000 after purchasing an additional 354 shares in the last quarter. Finally, Comerica Bank increased its stake in VanEck Pharmaceutical ETF by 39.4% during the 1st quarter. Comerica Bank now owns 1,337 shares of the company’s stock valued at $121,000 after purchasing an additional 378 shares in the last quarter.

VanEck Pharmaceutical ETF Trading Down 0.5 %

NASDAQ:PPH traded down $0.44 on Tuesday, reaching $90.25. 26,492 shares of the stock traded hands, compared to its average volume of 147,333. The company has a market capitalization of $666.95 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a 12 month low of $75.50 and a 12 month high of $99.51. The company’s fifty day simple moving average is $94.44 and its 200 day simple moving average is $93.03.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.